Directory
>
Kevin Lloyd
Kevin Lloyd
Vice President, Program Leadership | Morphic Therapeutic
Waltham, Massachusetts, United States
Kevin Lloyd
Summary
Kevin Lloyd is an accomplished Vice President of Program Leadership at Morphic Therapeutic, specializing in the biopharmaceutical and biotechnology sectors. With over two decades of experience in clinical operations and program management, he has successfully led teams in the development of innovative therapies in cardiology, oncology, and neurology. Kevin has a strong track record of navigating complex regulatory environments, having worked extensively with FDA regulations and good clinical practices. His leadership experience spans multiple organizations, showcasing his adaptability in both startup and corporate environments. Kevin's educational background in psychology and political science from the University of Vermont provides him with a unique perspective on team dynamics and stakeholder engagement. He is passionate about advancing drug development processes and improving patient outcomes through effective clinical research. Kevin is also known for his strategic thinking and problem-solving skills, which have been instrumental in driving successful clinical trials. He is a respected figure in the life sciences community, often sought after for his insights on clinical development.
Kevin Lloyd
Work Experience
Vice President, Program Leadership at
Morphic Therapeutic
January 2024 - Present
Vice President, Program & Alliance Management at
Leap Therapeutics
November 2020 - December 2023
Vice President, Program & Alliance Management at
Tetraphase Pharmaceuticals
December 2015 - July 2020
Executive Director, Clinical Operations & Program Management at
Tetraphase Pharmaceuticals
October 2013 - November 2015
Vice President, Development Operations at
Molecular Insight Pharmaceuticals
May 2012 - March 2013
Executive Director, Clinical Operations at
ZIOPHARM Oncology, Inc.
May 2011 - May 2012
Director, Clinical Business Operations at
Takeda Oncology
July 2006 - April 2011
Director, Clinical Operations at
ImmunoGen, Inc.
August 2005 - July 2006
Associate Director, Clinical Operations at
Takeda Oncology
December 2003 - August 2005
Senior Manager, Clinical Operations at
Takeda Oncology
June 2002 - December 2003
Manager, Clinical Development at
Biogen
May 2000 - May 2002
Clinical Project Manager at
Biogen
March 1998 - May 2000
Clinical Research Associate at
Parexel
December 1995 - March 1998
Research Coordinator at
Tufts Medical Center
July 1993 - September 1995
Kevin Lloyd
Education
January 1986 - January 1991
Frequently Asked Questions about Kevin Lloyd
What is Kevin Lloyd email address?
Kevin Lloyd's primary email address is ***********@mac.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kevin Lloyd work for?
Kevin Lloyd is a Vice President, Program Leadership at Morphic Therapeutic, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Kevin Lloyd graduated from?
Kevin Lloyd holds a degree in Psychology, Political Science from University of Vermont.
How can I directly contact Kevin Lloyd?
To contact Kevin Lloyd directly, you can use the email address ***********@mac.com. Complete contact information is available upon registration with Muraena.
Who is Kevin Lloyd?
Kevin Lloyd is an accomplished Vice President of Program Leadership at Morphic Therapeutic, specializing in the biopharmaceutical and biotechnology sectors. With over two decades of experience in clinical operations and program management, he has successfully led teams in the development of innovative therapies in cardiology, oncology, and neurology. Kevin has a strong track record of navigating complex regulatory environments, having worked extensively with FDA regulations and good clinical practices. His leadership experience spans multiple organizations, showcasing his adaptability in both startup and corporate environments. Kevin's educational background in psychology and political science from the University of Vermont provides him with a unique perspective on team dynamics and stakeholder engagement. He is passionate about advancing drug development processes and improving patient outcomes through effective clinical research. Kevin is also known for his strategic thinking and problem-solving skills, which have been instrumental in driving successful clinical trials. He is a respected figure in the life sciences community, often sought after for his insights on clinical development.
Kevin`s contact details
***********@mac.com
******@tphase.com
***********@morphictx.com
******@leaptx.com
Colleagues
Executive Director, Head of Molecular & Cellular Sciences
President
Sr. Vice President Finance & CAO
Executive Director, Head of Fibrosis
VP of DMPK & Clin Pharm
Vice President - Sr. Director, DMPK and Clinical PK at Morphic Therapeutic
VP, Head of Chemical Sciences
SVP, Technical Operations
Senior Vice President, Head of Biology and Translational Sciences